{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:43:28Z","timestamp":1765547008900,"version":"3.41.2"},"reference-count":34,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016047","name":"Science Fund of the Republic\nof Serbia","doi-asserted-by":"crossref","award":["7551100 - COVIDTARGET"],"award-info":[{"award-number":["7551100 - COVIDTARGET"]}],"id":[{"id":"10.13039\/501100016047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Drug resistance is a critical problem in health care that affects therapy outcomes and requires new approaches to drug design. SARS-CoV-2 Mpro mutations are of concern as they can potentially reduce therapeutic efficacy. Viral infections are amongst the many disorders for which nutraceuticals have been employed as an adjunct therapy. The aim of this study was to examine the potential in vitro activity of L-arginine and vitamin C against SARS-CoV-2 Mpro. Methods: The Mpro inhibition assay was developed by cloning, expression, purification, and characterization of Mpro. Selected compounds were then screened for protease inhibition. Results: L-arginine was found to be active against SARS-CoV-2 Mpro, while a vitamin C\/L-arginine combination had a synergistic antiviral action against Mpro. These findings confirm the results of our previous in silico repurposing study that showed L-arginine and vitamin C were potential Mpro inhibitors. Moreover, they suggest a possible molecular mechanism to explain the beneficial effect of arginine in COVID patients. Conclusions: The findings of the current study are important because they help to identify COVID-19 treatments that are efficient, inexpensive, and have a favorable safety profile. The results of this study also suggest a possible adjuvant nutritional strategy for COVID-19 that could be used in conjunction with pharmacological agents.<\/jats:p>","DOI":"10.31083\/j.fbl2801008","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T09:20:10Z","timestamp":1673601610000},"source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C\/L-Arginine Combination"],"prefix":"10.31083","volume":"28","author":[{"given":"Ivana","family":"\u0110uki\u0107","sequence":"first","affiliation":[{"name":"University of Belgrade-Faculty of Chemistry, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevena","family":"Kali\u010danin","sequence":"first","affiliation":[{"name":"University of Belgrade-Institute of Chemistry, Technology and Metallurgy, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Sencanski","sequence":"first","affiliation":[{"name":"Laboratory of Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snezana B.","family":"Pajovic","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Endocrinology, VINCA Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Milicevic","sequence":"first","affiliation":[{"name":"Laboratory of Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Prljic","sequence":"first","affiliation":[{"name":"Laboratory of Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan","family":"Paessler","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA"},{"name":"Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radivoje","family":"Prodanovi\u0107","sequence":"first","affiliation":[{"name":"University of Belgrade-Faculty of Chemistry, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Glisic","sequence":"first","affiliation":[{"name":"Laboratory of Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Guarner J. Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19. American Journal of Clinical Pathology. 2020; 153: 420\u2013421.","DOI":"10.1093\/ajcp\/aqaa029"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine. 2020; 382: 1708\u20131720.","DOI":"10.1056\/NEJMoa2002032"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497\u2013506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. Journal of Neuroinflammation. 2020; 17: 231.","DOI":"10.1186\/s12974-020-01896-0"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. International Journal of Molecular Sciences. 2021; 22: 2681.","DOI":"10.3390\/ijms22052681"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Subedi L, Tchen S, Gaire BP, Hu B, Hu K. Adjunctive Nutraceutical Therapies for COVID-19. International Journal of Molecular Sciences. 2021; 22: 1963.","DOI":"10.3390\/ijms22041963"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mahar Doan KM, Lakhman SS, Boje KM. Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique. Brain Research. 2000; 876: 141\u2013147.","DOI":"10.1016\/S0006-8993(00)02643-3"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, et al. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021; 40: 101125.","DOI":"10.1016\/j.eclinm.2021.101125"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kneller DW, Phillips G, O\u2019Neill HM, Jedrzejczak R, Stols L, Langan P, et al. Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nature Communications. 2020; 11: 3202.","DOI":"10.1038\/s41467-020-16954-7"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sencanski M, Perovic V, Pajovic SB, Adzic M, Paessler S, Glisic S. Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method. Molecules. 2020; 25: 3830.","DOI":"10.3390\/molecules25173830"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Veljkovic N, Glisic S, Perovic V, Veljkovic V. The role of long-range intermolecular interactions in discovery of new drugs. Expert Opinion on Drug Discovery. 2011; 6: 1263\u20131270.","DOI":"10.1517\/17460441.2012.638280"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Singh P, Kumar D, Pal S, Kumari K, Bahadur I. L-amino-acids as immunity booster against COVID-19: DFT, molecular docking and MD simulations. Journal of Molecular Structure. 2022; 1250: 131924.","DOI":"10.1016\/j.molstruc.2021.131924"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Malla TN, Pandey S, Aldama L, Feliz D, Noda M, Poudyal I, et al. Vitamin C Binds to SARS Coronavirus-2 Main Protease Essential for Viral Replication. bioRxiv. 2021. (preprint)","DOI":"10.1101\/2021.05.02.442358"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Drouin G, Godin J, Pag\u00e9 B. The genetics of vitamin C loss in vertebrates. Current Genomics. 2011; 12: 371\u2013378.","DOI":"10.2174\/138920211796429736"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Hoang BX, Shaw G, Fang W, Han B. Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection. Journal of Global Antimicrobial Resistance. 2020; 23: 256\u2013262.","DOI":"10.1016\/j.jgar.2020.09.025"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, et al. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients. 2020; 12: 3760.","DOI":"10.3390\/nu12123760"},{"key":"ref17","unstructured":"Ivarsson, Y. pETM33_Nsp5_Mpro Addgene plasmid # 156475. 2021. Available at: https:\/\/www.addgene.org\/156475\/ (Accessed: 1 September 2021)."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy N, Fakhro K. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease. IUBMB Life. 2021; 73: 670\u2013675.","DOI":"10.1002\/iub.2465"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Defelice SL. The nutraceutical revolution: its impact on food industry R&D. Trends in Food Science & Technology. 1995; 6: 59\u201361.","DOI":"10.1016\/S0924-2244(00)88944-X"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Izzo R, Trimarco V, Mone P, Alo\u00e8 T, Capra Marzani M, Diana A, et al. Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacological Research. 2022; 183: 106360.","DOI":"10.1016\/j.phrs.2022.106360"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Li P, Wu G. Important roles of amino acids in immune responses. The British Journal of Nutrition. 2022; 127: 398\u2013402.","DOI":"10.1017\/S0007114521004566"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Chen L, Liu P, Gao H, Sun B, Chao D, Wang F, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clinical Infectious Diseases. 2004; 39: 1531\u20131535.","DOI":"10.1086\/425357"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Alvares TS, Conte-Junior CA, Silva JT, Paschoalin VM. Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects. Nutrition & Metabolism. 2020; 9: 54.","DOI":"10.1186\/1743-7075-9-54"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Skwarecki AS, Nowak MG, Milewska MJ. Amino Acid and Peptide-Based Antiviral Agents. ChemMedChem. 2021; 16: 3106\u20133135.","DOI":"10.1002\/cmdc.202100397"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Abobaker A, Alzwi A, Alraied AHA. Overview of the possible role of vitamin C in management of COVID-19. Pharmacological Reports. 2020; 72: 1517\u20131528.","DOI":"10.1007\/s43440-020-00176-1"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition. 2020; 79\u201380: 110948.","DOI":"10.1016\/j.nut.2020.110948"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Holford P, Carr AC, Zawari M, Vizcaychipi MP. Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence. Life. 2021; 11: 1166.","DOI":"10.3390\/life11111166"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hazan S, Stollman N, Bozkurt HS, Dave S, Papoutsis AJ, Daniels J, et al. Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterology. 2022; 9: e000871.","DOI":"10.1136\/bmjgast-2022-000871"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Shu G, Yang Q, He C. Effect of ascorbic acid and cysteine hydrochloride on growth of Bifidobacterium bifidum. Advance Journal of Food Science and Technology. 2013; 5: 678\u2013681.","DOI":"10.19026\/ajfst.5.3148"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kontermann RE. Dual targeting strategies with bispecific antibodies. Taylor & Francis. 2012; 4: 182\u2013197.","DOI":"10.4161\/mabs.4.2.19000"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Hill JA, Cowen LE. Using combination therapy to thwart drug resistance. Future Microbiology. 2015; 10: 1719\u20131726.","DOI":"10.2217\/fmb.15.68"},{"key":"ref32","unstructured":"Jezovnik M, Poredos P. Oxidative stress and atherosclerosis. European Society of Cardiology. 2007; 6: 306\u2013311."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Grzegorowska O, Lorkowski J. Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19. Journal of Clinical Medicine. 2020; 9: 3746.","DOI":"10.3390\/jcm9113746"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Bogda\u0144ski P, Suliburska J, Szuli\u0144ska M, Sikora M, Walkowiak J, Jakubowski H. L-Arginine and vitamin C attenuate pro-atherogenic effects of high-fat diet on biomarkers of endothelial dysfunction in rats. Biomedicine & Pharmacotherapy. 2015; 76: 100\u2013106.","DOI":"10.1016\/j.biopha.2015.10.001"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/1\/10.31083\/j.fbl2801008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T12:31:50Z","timestamp":1732710710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/28\/1\/10.31083\/j.fbl2801008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2768-6701(22)00744-4"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2801008","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"type":"print","value":"2768-6701"},{"type":"electronic","value":"2768-6698"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"article-number":"8"}}